Liver Cancer–Specific Serine Protease Inhibitor Kazal Is a Potentially Novel Biomarker for the Early Detection of Hepatocellular Carcinoma

Liver cancer-secreted serine protease inhibitor Kazal (LC-SPIK) is a protein that is specifically elevated in cases of hepatocellular carcinoma (HCC). We assessed the performance of LC-SPIK in detecting HCC, including its early stages, in patients with cirrhosis, hepatitis B virus (HBV), and hepatit...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Clinical and translational gastroenterology 2020-12, Vol.11 (12), p.e00271-e00271
Hauptverfasser:	Lu, Felix, Shah, Pir Ahmad, Rao, Abhishek, Gifford-Hollingsworth, Cynthia, Chen, Anne, Trey, Gary, Soryal, Mina, Talat, Arslan, Aslam, Aysha, Nasir, Bilal, Choudhry, Saad, Ishtiaq, Rizwan, Sanoff, Hanna, Conteh, Lanla F., Noonan, Anne, Hu, Ke-Qin, Schmidt, Carl, Fu, Min, Civan, Jesse, Xiao, Gary, Lau, Daryl T.-Y., Lu, Xuanyong
Format:	Artikel
Sprache:	eng
Schlagworte:	Biomarkers Hepatitis Liver Liver cancer Liver cirrhosis Liver diseases Medical diagnosis Medical prognosis Monoclonal antibodies Patients Proteins Surveillance Ultrasonic imaging Validation studies
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!